National Medical Care
This article was originally published in The Gray Sheet
Executive Summary
Company's January 1994 consent decree with FDA was dissolved in January 1997. "The Gray Sheet" (1Oct. 4, p. 16) incorrectly stated the consent decree was entered in February 1997
You may also be interested in...
Abbott Facing FDA Consent Decree Over Alleged QSR Violations
Discussions between Abbott Labs and FDA over a proposed consent decree that could halt production of certain diagnostic products likely relate to quality system regulations (QSR) violations detected over a year ago at the firm's Abbott Park, Illinois facility.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.